magnesium sulfate has been researched along with Premature Birth in 167 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 14 (8.38) | 29.6817 |
| 2010's | 108 (64.67) | 24.3611 |
| 2020's | 45 (26.95) | 2.80 |
| Authors | Studies |
|---|---|
| Callander, E; Cavallaro, A; Crowther, C; Groves, C; Keir, A; Mcintyre, S; Rumbold, A; Shepherd, E | 1 |
| David, AL; Mendonça, M; Morgan, AS; Thiele, N | 1 |
| Alsweiler, J; Bastin, ME; Boardman, JP; Crowther, CA; Deib, G; Harding, JE; Poppe, T; Thompson, B | 1 |
| Carlsson, Y; Hagberg, H; Jonsdotter, A; Rocha-Ferreira, E | 1 |
| Athanasiadis, A; Dagklis, T; Giouleka, S; Kalogiannidis, I; Kostakis, N; Koutsouki, G; Mamopoulos, A; Tsakiridis, I | 1 |
| Chou, D; Coomarasamy, A; Gallos, ID; Hodgetts-Morton, VA; Larkai, E; Markland, AD; Marson, EJ; Morris, K; Oladapo, OT; Papadopoulou, A; Price, MJ; Tobias, A; Wilson, A | 1 |
| Althabe, F; Bohren, MA; Eddy, KE; Hazfiarini, A; Minckas, N; Oladapo, OT; Tunçalp, Ӧ; Vogel, JP; Zahroh, RI | 1 |
| Liu, Q; Lu, SJ; Xiao, L; Yu, YC; Zhao, LR | 1 |
| Alon, D; Beloosesky, R; Dabbah-Assadi, F; Doron, R; Golani, I; Palzur, E; Rashid, S; Rubinstein, A; Shamir, A | 1 |
| Bennet, L; Davidson, JO; Dhillon, SK; Galinsky, R; Gunn, AJ; Kelly, SB; Lear, CA; van den Heuij, LG; Wassink, G | 1 |
| Akello, J; Alia, G; Mwaka, S; Namusoke, F | 1 |
| Keshtmandi, H; Mirmohammadkhani, M; Rahmanian, M | 1 |
| Ashwood, P; Crowther, CA; Harding, JE; McPhee, A; Middleton, PF; Tran, T | 1 |
| Ådén, U; Ågren, J; Carlsson, Y; Domellöf, M; Hagberg, H; Hellström, S; Herbst, A; Jonsdotter, A; Jonsson, M; Pettersson, K; Saltvedt, S | 1 |
| Carrascosa García, P; Fernández Monteagudo, B; Sánchez Luna, M; Villar Castro, S; Zeballos Sarrato, S | 1 |
| Akolekar, R; Allegaert, K; Chaveeva, P; Dagklis, T; Jekova, N; Kesrouani, A; Khalil, A; Kusuda, S; Plasencia, W; Prefumo, F; Sen, C; Tekay, A; Tsakiridis, I; Villalain, C; Volpe, N; Wellmann, S | 1 |
| Ahn, SY; Chang, YS; Choi, SJ; Jeon, GW; Kim, SM; Oh, SY; Roh, CR; Sung, JH; Sung, SI; Yang, M | 1 |
| Chappell, L; De Oliveira, L; Dias, MAB; Jeyabalan, A; Magee, L; Payne, B; Poston, L; Redman, CW; Roberts, JM; Seed, P; von Dadelszen, P | 1 |
| Hagberg, H; Jacobsson, B; Leijonhufvud, Å; Morken, NH; Saltvedt, S; Wikström, AK | 1 |
| Crowther, CA; Makrides, M; Manhas, D; Middleton, P; Salam, RA; Shepherd, E; Synnes, A | 1 |
| Ellwood, D; Homer, CSE; Jackson Pulver, L; Knight, M; Li, Z; McLintock, C; Peek, MJ; Pollock, W; Sullivan, EA; Vaughan, G; Wang, A | 1 |
| Fujita, K; Moriuchi, K; Sakae-Matsumoto, C; Sato, Y; Ueda, M | 1 |
| Canpolat, FE; Kutman, HGK; Oğuz, SS; Oğuz, Y; Ozer Bekmez, B; Tayman, C; Uygur, D | 1 |
| Chen, YT; Chiu, HY; Chu, SM; Lin, HC; Lin, HY; Tsai, ML | 1 |
| Brok, J; Greisen, G; Hedegaard, M; Hegaard, HK; Henriksen, TB; Huusom, LD; Pinborg, A; Pryds, O; Salvig, JD; Weber, T; Wolf, HT | 2 |
| Brok, J; Hegaard, HK; Henriksen, TB; Huusom, LD; Pinborg, A; Wolf, HT | 1 |
| Browne, PC; Linfert, JB; Perez-Jorge, E | 1 |
| Grobman, WA | 1 |
| Greisen, G; Hoei-Hansen, CE; Krebs, L; Larsen, ML; Rackauskaite, G | 1 |
| Stefanovic, V | 1 |
| Athanasiadis, A; Dagklis, T; Mamopoulos, A; Tsakiridis, I | 1 |
| Bos, AF; Dikkers, R; Kooi, EMW; Richter, AE; Scherjon, SA | 1 |
| Ahn, SY; Chang, YS; Choi, SJ; Choi, YS; Hong, JY; Kim, HS; Kim, YM; Oh, SY; Park, WS; Roh, CR; Sung, JH; Sung, SI | 1 |
| da Silva Costa, F; Fenn, S; Mol, BW; Palmer, KR; Reddy, M; Rolnik, DL; Wallace, EM | 1 |
| Blanchard, CT; Harper, LM; Harris, SL; Robbins, LS; Sinkey, RG; Tita, AT | 1 |
| Chauhan, SP; Mendez-Figueroa, H | 1 |
| Brackney, K; Gibson, KS | 1 |
| Emeruwa, UN; Krenitsky, NM; Sheen, JJ | 1 |
| Brok, JS; Hegaard, HK; Henriksen, TB; Huusom, LD; Larsen, ML; Pinborg, A; Wolf, HT | 1 |
| Agbal, T; Caglar, AT; Celen, S; Orgul, G | 1 |
| Bellos, I; Constantinou, T; Daskalakis, G; Loutradis, D; Papapanagiotou, A; Pergialiotis, V; Voskos, A | 1 |
| Anderson, PJ; Boland, RA; Cheong, JLY; Doyle, LW; Kwong, A; Lee, KJ; Olsen, JE; Spittle, AJ | 1 |
| Bertrand, E; Chollat, C; Dabaj, I; de Vansay, C; Gillibert, A; Marret, S; Petit-Ledo, A; Voisin, C | 1 |
| Callander, EJ; Crowther, C; Groves, C; Keir, AK; McIntyre, S; Rumbold, A; Shepherd, E | 1 |
| Edwards, JM; Edwards, LE; Grotegut, CA; Swamy, GK | 2 |
| Chien, EK; Gibson, KS | 1 |
| Amaral, LM; LaMarca, B; Owens, M; Wallace, K | 1 |
| Pang, J | 1 |
| Brown, HL; Gregory, KD; Grobman, WA; Iriye, BK; Saade, GR | 1 |
| Badawi, N; Crowther, CA; Makrides, M; McIntyre, S; Middleton, P; Salam, RA; Shepherd, E | 1 |
| Barrett, JFR; Chari, RS; Dunn, MS; Jones, G; Ladhani, NNN; Shah, P | 1 |
| Chollat, C; de la Villéon, G; Le Doussal, L; Marret, S; Provost, D | 1 |
| Chiossi, G; Costantine, MM; Discacciati, A; Hadley, EE; Munn, MB; Pacheco, LD; Saade, GR | 1 |
| Askie, L; Crowther, CA; Doyle, LW; Duley, L; Marret, S; Middleton, PF; Pryde, PG; Voysey, M | 1 |
| Dietz, RM; Paulsen, ME | 1 |
| Murray, SR; Norman, JE; Stock, SJ | 1 |
| Kingdom, JC; Shah, PS; Ting, JY | 1 |
| Alfirevic, Z; Mammarella, S; Medley, N; Poljak, B | 1 |
| Caritis, SN; Clark, EAS; Dudley, DJ; Hankins, GDV; Iams, JD; Malone, FD; Mercer, BM; O'Sullivan, MJ; Peaceman, AM; Reddy, UM; Rouse, DJ; Sorokin, Y; Wapner, RJ; Weiner, SJ | 1 |
| Abrahams, VM; Cross, SN; Nelson, RA; Norwitz, ER; Potter, JA | 1 |
| Huusom, LD; Wolf, HT | 1 |
| Govindaswami, B; Jegatheesan, P; Narasimhan, SR; Nudelman, M | 1 |
| Azria, E | 1 |
| Buhimschi, CS; Buhimschi, IA; Hay, K; Kellert, BA; Maitre, NL; Stetson, BT | 1 |
| Buhimschi, C; Caritis, SN; Carpenter, M; Costantine, MM; Dudley, DJ; Jablonski, KA; Leveno, KJ; Malone, FD; Mercer, BM; O'sullivan, MJ; Peaceman, AM; Ramin, SM; Reddy, UM; Rouse, DJ; Sorokin, Y; Thorp, JM; Varner, MW; Wapner, RJ | 1 |
| Brookfield, KF; Vinson, A | 1 |
| De Silva, DA; Magee, LA; Sawchuck, D; Synnes, A; von Dadelszen, P | 1 |
| Bernstein, HB; Jameson, RA | 1 |
| Akbar, MIA; Bachnas, MA; Dachlan, EG; Dekker, G | 1 |
| Crowther, C; Gatman, K; May, R | 1 |
| Andersson, S; Stefanovic, V; Vento, M | 1 |
| Ashwood, P; Crowther, CA; Haslam, R; Middleton, PF; Wilkinson, D | 1 |
| Bernstein, HB; Ramirez Kitchen, CM; Romani, AM; Sugimoto, J; Suzuki-Kakisaka, H; Tetarbe, M | 1 |
| Crowther, CA; Han, S; Moore, V | 2 |
| Ashwood, P; Bain, E; Bubner, T; Crowther, C; Goodchild, L; Lontis, R; McIntyre, S; Middleton, P | 1 |
| Borowiack, E; Khan, K; Kowalska, M; Meads, C; Mignini, L; Mol, B; Roos, C; Walczak, J; Zapalska, A | 1 |
| Andonotopo, W; Bachnas, MA; Effendi, JS; Mose, JC | 1 |
| Bain, ES; Crowther, CA; Middleton, PF | 1 |
| Basso, M; Bickford, CD; Kruse, M; Magee, LA; Mitton, C; Sawchuck, D; Senikas, VM; Synnes, AR; von Dadelszen, P | 1 |
| Ashwood, P; Bain, E; Bubner, T; Crowther, CA; Flenady, V; McIntyre, S; Middleton, PF; Morris, J | 1 |
| Drack, G; Hösli, I; Irion, O; Sperschneider, C; Surbek, D; Zimmermann, R | 1 |
| Ashwood, PJ; Bain, ES; Crowther, CA; Middleton, PF; Yelland, LN | 1 |
| Koren, G; Namouz-Haddad, S | 1 |
| Abenhaim, HA; Gangal, M; Xiao, C | 1 |
| Bhandari, HM; Gorecha, M; Woodman, J | 1 |
| Manuck, TA; Sheng, X; Varner, MW; Yoder, BA | 1 |
| Arbona-Ramirez, IM; Dorsey, MJ; Funderburg, N; Llorens-Bonilla, BJ; Luciano, AA; Martinez-Lopez, DG; Ruiz, R | 1 |
| Chattopadhyay, S; Das, A; Pahari, S | 1 |
| Caritis, SN; Carpenter, M; Dudley, DJ; Hankins, GD; Iams, JD; Jablonski, KA; Leveno, KJ; Malone, FD; Marshall, NE; Mercer, BM; O'Sullivan, MJ; Peaceman, AM; Reddy, UM; Rouse, DJ; Sorokin, Y; Thorp, JM; Varner, MW; Wapner, RJ | 1 |
| Arora, KS; Miller, ES | 1 |
| Brown, J; Crowther, CA; McKinlay, CJ; Middleton, P | 1 |
| Grobman, WA; McPherson, JA; Palatnik, A; Rouse, DJ; Stamilio, DM | 1 |
| Haas, J; Kalter, A; Marom-Haham, L; Mazaki-Tovi, S; Schiff, E; Sivan, E; Yinon, Y; Zilberman, I | 1 |
| Anderson, PJ; Crowther, C; Doyle, LW; Haslam, R; Lee, KJ | 1 |
| Groom, KM; Tan, YH | 1 |
| Jacquemyn, Y; Roelens, K; Van Laere, D; Zecic, A | 1 |
| Cho, GJ; Hong, HR; Hong, SC; Kim, HJ; Oh, MJ | 1 |
| Grogan, SP; Seehusen, DA | 1 |
| Bozkurt, O; Canpolat, FE; Dilmen, U; Eras, Z; Oguz, SS; Uras, N | 1 |
| Allard, D; Bousleiman, SZ; Dorman, K; Johnson, F; Mallett, G; Milluzzi, C; Moss, J; Ortiz, F; Reed, P; Rice, MM; Rincon, M; Todd, A; Tolivaisa, S | 1 |
| Consonni, S; Ghidini, A; Locatelli, A | 1 |
| Drassinower, D; Friedman, AM; Gyamfi-Bannerman, C; Levin, H; Običan, SG | 2 |
| Clark, E; Kamyar, M; Manuck, TA; Stoddard, GJ; Varner, MW | 1 |
| Dos Santos, RA; Flenady, V; Kumar, S; Pileggi-Castro, C; Reinebrant, HE; Romero, CL; Souza, JP | 1 |
| Ashwood, P; Bain, E; Bubner, T; Crowther, CA; Middleton, P; Siwicki, K | 1 |
| Drassinower, D; Gyamfi-Bannerman, C; Levin, H; Običan, SG; Small, A; Smith, D | 1 |
| McPherson, J; Smiley, S; Stamilio, D | 1 |
| Izbizky, G; Meller, CH; Otaño, L | 1 |
| Ashwood, P; Bain, E; Bubner, T; Crowther, CA; Middleton, P; Reid, S; Simmonds, L; Van Ryswyk, E | 1 |
| DeWitt, PE; Faucett, AM; Gibbs, RS; Metz, TD | 1 |
| Chigusa, Y; Kawasaki, K; Kondoh, E; Konishi, I; Mogami, H; Ueda, A | 1 |
| Brown, J; Crowther, CA; McNamara, HC | 1 |
| Basso, M; Chapman, K; De Silva, DA; Liston, RM; Magee, LA; Sawchuck, D; Synnes, AR; Teela, KC; von Dadelszen, P | 1 |
| Berger, VK; Chock, VY; Davis, AS | 1 |
| Berghella, V; Navathe, R | 1 |
| Hirtz, D; Rouse, DJ | 1 |
| Morag, I; Schushan-Eisen, I; Siman-Tov, M; Simchen, M; Stern, O; Strauss, T; Yakubovich, D | 1 |
| Gyamfi-Bannerman, C; Too, GT; Turitz, AL | 1 |
| Ananth, CV; Lavery, JA | 1 |
| Marasinghe, JP | 1 |
| Kamyar, M | 1 |
| Azad, K; Mathews, J | 1 |
| Escalona-Vargas, DI; Eswaran, H; Lowery, CL; Magann, EF; McGrail, K; Napolitano, PG; Thagard, AS | 1 |
| Rafi, J | 1 |
| Arakaki, T; Hamada, S; Hasegawa, J; Koide, K; Matsuoka, R; Nakamura, M; Oba, T; Sekizawa, A; Takita, H | 1 |
| McPherson, JA; Smid, MC; Smiley, S; Stamilio, DM | 1 |
| Huusom, L; Norman, M; Piedvache, A; Schmidt, S; Weber, T; Wolf, HT; Zeitlin, J | 1 |
| Ancel, PY; Marret, S | 1 |
| Crowther, C; Stanley, FJ | 1 |
| Crowther, CA; Doyle, LW; Marret, S; Middleton, P; Rouse, D | 1 |
| Gokdagli, F; Goynumer, G; Gunduz, G; Guzin, K; Kayabasoglu, F; Turkgeldi, E | 1 |
| Bastek, JA; Elovitz, MA; Sammel, MD; Srinivas, SK | 1 |
| Scott, JR | 1 |
| Mercer, BM; Merlino, AA | 1 |
| Blumenfeld, YJ; Lyell, DJ | 1 |
| Marret, S | 1 |
| Garrison, AW | 1 |
| Chen, SU; Ho, HN; Lee, CN; Wu, MY; Yang, YS | 1 |
| Clark, SL; Gibbs, RS; Reeves, SA | 1 |
| Dubuisson, JB; Irion, O; Julen, O; Lourenço, AG; Yaron, M | 1 |
| Clark, EA; Varner, M | 1 |
| Magee, L; Sawchuck, D; Synnes, A; von Dadelszen, P | 1 |
| Sibai, BM | 1 |
| Evans, N; Kluckow, M; Osborn, DA; Paradisis, M | 1 |
| Bain, E; Crowther, CA; Middleton, P | 1 |
| Combs, CA; Garite, TJ | 1 |
| Kennedy, A; McCarthy, EA; Ow, LL; Walker, SP | 1 |
| Dean, C; Douglas, J | 1 |
| Doggrell, SA | 1 |
| Itakura, A; Matsuzawa, K; Mizutani, S; Murata, Y; Okumura, A; Wakai, K | 1 |
| Bahtiyar, MO; Norwitz, ER; Sibai, BM | 1 |
| Dowling, O; Metz, CN; Rochelson, B; Schwartz, N | 1 |
| Crowther, CA; Doyle, LW; Marret, S; Middleton, P | 1 |
| Caritis, SN; Simhan, HN | 1 |
| Bénichou, J; Marpeau, L; Marret, S | 1 |
| Barkin, AZ; Kang, TL; Sanchez, LD | 1 |
| Kam, KY; Lamont, RF | 1 |
57 review(s) available for magnesium sulfate and Premature Birth
| Article | Year |
|---|---|
Preterm Labor: A Comprehensive Review of Guidelines on Diagnosis, Management, Prediction and Prevention.
Topics: Adrenal Cortex Hormones; Cervix Uteri; Female; Humans; Infant, Newborn; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy; Premature Birth; Tocolytic Agents | 2022 |
Tocolytics for delaying preterm birth: a network meta-analysis (0924).
Topics: Adrenergic beta-Agonists; Birth Weight; Calcium Channel Blockers; Child; Female; Headache; Humans; Infant, Newborn; Magnesium Sulfate; Network Meta-Analysis; Nitric Oxide Donors; Pregnancy; Premature Birth; Randomized Controlled Trials as Topic; Receptors, Oxytocin; Tocolytic Agents; Vomiting | 2022 |
Factors influencing appropriate use of interventions for management of women experiencing preterm birth: A mixed-methods systematic review and narrative synthesis.
Topics: Anti-Bacterial Agents; Female; Humans; Infant, Newborn; Magnesium Sulfate; Parturition; Pregnancy; Premature Birth; Tocolytic Agents | 2022 |
Management of preterm labor: Clinical practice guideline and recommendation by the WAPM-World Association of Perinatal Medicine and the PMF-Perinatal Medicine Foundation.
Topics: Female; Humans; Infant, Newborn; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy; Premature Birth; Tocolytic Agents | 2023 |
[Preterm delivery: an overview on prediction, prevention and treatment].
Topics: Adrenal Cortex Hormones; Biomarkers; Cerclage, Cervical; Cervical Length Measurement; Cervix Uteri; Female; Fibronectins; Humans; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Pessaries; Pre-Eclampsia; Pregnancy; Premature Birth; Prenatal Care; Progesterone; Sweden; Tocolytic Agents | 2019 |
Antenatal magnesium sulphate and adverse neonatal outcomes: A systematic review and meta-analysis.
Topics: Case-Control Studies; Eclampsia; Female; Humans; Magnesium Sulfate; Obstetric Labor, Premature; Parturition; Pre-Eclampsia; Pregnancy; Premature Birth; Prenatal Care; Prospective Studies | 2019 |
Evidence base multi-discipline critical strategies toward better tomorrow for very preterm infants.
Topics: Anti-Bacterial Agents; Bronchopulmonary Dysplasia; Budesonide; Caffeine; Central Nervous System Stimulants; Chorioamnionitis; Continuous Positive Airway Pressure; Counseling; Decision Making, Shared; Enteral Nutrition; Evidence-Based Practice; Female; Glucocorticoids; Humans; Hypotension; Hypothermia; Infant; Infant, Extremely Premature; Infant, Newborn; Magnesium Sulfate; Neurodevelopmental Disorders; Parenteral Nutrition; Patient Care Team; Pregnancy; Premature Birth; Prenatal Care; Probiotics; Pulmonary Surfactants; Resuscitation; Tocolytic Agents | 2020 |
Magnesium sulphate for fetal neuroprotection at imminent risk for preterm delivery: a systematic review with meta-analysis and trial sequential analysis.
Topics: Cerebral Palsy; Female; Humans; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Premature Birth; Prenatal Care; Randomized Controlled Trials as Topic; Risk Assessment | 2020 |
Antenatal Corticosteroids and Magnesium Sulfate for Improved Preterm Neonatal Outcomes: A Review of Guidelines.
Topics: Adrenal Cortex Hormones; Cesarean Section; Drug Administration Schedule; Female; Humans; Magnesium Sulfate; Practice Guidelines as Topic; Pregnancy; Premature Birth; Prenatal Care; Tocolytic Agents | 2020 |
Tocolytic Therapy in Preterm Premature Rupture of Membranes.
Topics: Adrenal Cortex Hormones; Female; Fetal Membranes, Premature Rupture; Humans; Infant, Newborn; Magnesium Sulfate; Pregnancy; Premature Birth; Ritodrine; Tocolysis; Tocolytic Agents | 2020 |
Periviable Premature Rupture of Membranes.
Topics: Adrenal Cortex Hormones; Amniotic Fluid; Anti-Bacterial Agents; Bronchopulmonary Dysplasia; Cerclage, Cervical; Chorioamnionitis; Female; Fetal Membranes, Premature Rupture; Fetal Viability; Gestational Age; Humans; Infant, Extremely Premature; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Pregnancy; Pregnancy Outcome; Premature Birth | 2020 |
Advances in Management for Preterm Fetuses at Risk of Delivery.
Topics: Anti-Bacterial Agents; Anticonvulsants; Betamethasone; Dexamethasone; Female; Fetal Membranes, Premature Rupture; Fetal Organ Maturity; Fetal Viability; Glucocorticoids; Humans; Indomethacin; Magnesium Sulfate; Neonatal Sepsis; Neuroprotective Agents; Nifedipine; Pregnancy; Premature Birth; Streptococcal Infections; Streptococcus agalactiae; Tocolysis; Tocolytic Agents | 2020 |
[Magnesium sulphate treatment decreases the risk of cerebral palsy after preterm birth].
Topics: Cerebral Palsy; Child; Female; Humans; Infant, Newborn; Magnesium Sulfate; Neuroprotection; Neuroprotective Agents; Pregnancy; Premature Birth; Prenatal Care; Randomized Controlled Trials as Topic | 2020 |
Magnesium sulfate and risk of postpartum uterine atony and hemorrhage: A meta-analysis.
Topics: Female; Humans; Infant, Newborn; Magnesium Sulfate; Postpartum Hemorrhage; Postpartum Period; Pregnancy; Premature Birth; Uterine Inertia | 2021 |
Medical and Surgical Interventions Available Before a Periviable Birth.
Topics: Adrenal Cortex Hormones; Amniocentesis; Cerclage, Cervical; Female; Fetal Viability; Humans; Infant, Extremely Premature; Infant, Newborn; Magnesium Sulfate; Pregnancy; Premature Birth; Progesterone; Progestins; Tocolysis; Tocolytic Agents | 2017 |
Pathophysiology and Current Clinical Management of Preeclampsia.
Topics: Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Delivery, Obstetric; Endothelium, Vascular; Female; Humans; Hydralazine; Infant, Low Birth Weight; Infant, Newborn; Inflammation; Ischemia; Labetalol; Magnesium Sulfate; Placenta; Pre-Eclampsia; Pregnancy; Premature Birth | 2017 |
Antenatal and intrapartum interventions for preventing cerebral palsy: an overview of Cochrane systematic reviews.
Topics: Antibiotic Prophylaxis; Cerebral Palsy; Female; Fetal Distress; Humans; Hypertension; Infant, Premature; Magnesium Sulfate; Neuroprotective Agents; Parturition; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Premature Birth; Prenatal Care; Randomized Controlled Trials as Topic; Review Literature as Topic | 2017 |
Assessing the neuroprotective benefits for babies of antenatal magnesium sulphate: An individual participant data meta-analysis.
Topics: Cerebral Palsy; Dose-Response Relationship, Drug; Female; Fetal Blood; Gestational Age; Humans; Infant; Infant Mortality; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Neuroprotective Agents; Outcome and Process Assessment, Health Care; Pregnancy; Premature Birth; Prenatal Care; Randomized Controlled Trials as Topic; Time-to-Treatment | 2017 |
Long-term childhood outcomes after interventions for prevention and management of preterm birth.
Topics: Administration, Intravaginal; Adult; Cerclage, Cervical; Child; Child Development; Female; Follow-Up Studies; Humans; Infant, Newborn; Magnesium Sulfate; Patient Outcome Assessment; Pessaries; Pregnancy; Premature Birth; Prenatal Care; Progesterone; Progestins; Time Factors; Tocolytic Agents | 2017 |
Antenatal glucocorticoids, magnesium sulfate, and mode of birth in preterm fetal small for gestational age.
Topics: Calcium Channel Blockers; Cesarean Section; Delivery, Obstetric; Female; Fetal Growth Retardation; Gestational Age; Glucocorticoids; Humans; Infant, Newborn; Infant, Premature; Infant, Small for Gestational Age; Labor, Induced; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Premature Birth; Prenatal Care | 2018 |
Clinical guidelines for prevention and management of preterm birth: a systematic review.
Topics: Cervical Length Measurement; Female; Humans; Magnesium Sulfate; Practice Guidelines as Topic; Pregnancy; Premature Birth; Prenatal Care; Steroids; Tocolysis | 2018 |
Antenatal magnesium sulfate treatment for women at risk of preterm birth is safe and might decrease the risk of cerebral palsy.
Topics: Cerebral Palsy; Female; Humans; Infant; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Pregnancy; Premature Birth; Prenatal Care | 2018 |
Prevention of Prematurity: Advances and Opportunities.
Topics: Anti-Infective Agents; Aspirin; Cerclage, Cervical; Cesarean Section; Female; Humans; Indomethacin; Labor, Induced; Magnesium Sulfate; Nifedipine; Pharmacogenetics; Platelet Aggregation Inhibitors; Preconception Care; Pregnancy; Premature Birth; Progesterone; Progestins; Reproductive Techniques, Assisted; Smoking Cessation; Tocolytic Agents | 2018 |
Magnesium sulfate use for fetal neuroprotection.
Topics: Central Nervous System Diseases; Dose-Response Relationship, Drug; Female; Humans; Infant, Premature, Diseases; Magnesium Sulfate; Maternal-Fetal Exchange; Neuroprotective Agents; Pregnancy; Premature Birth; Prenatal Care; Retrospective Studies; Risk Assessment | 2019 |
Magnesium Sulfate and Novel Therapies to Promote Neuroprotection.
Topics: Cerebral Palsy; Darbepoetin alfa; Erythropoietin; Female; Hematinics; Humans; Hypothermia, Induced; Infant, Newborn; Infant, Premature; Ischemic Preconditioning; Magnesium Sulfate; Maternal-Fetal Exchange; Mesenchymal Stem Cell Transplantation; Neuroprotection; Neuroprotective Agents; Obstetric Labor, Premature; Pregnancy; Premature Birth | 2019 |
The role of magnesium sulfate (MgSO
Topics: Female; Humans; Infant, Newborn; Magnesium Sulfate; Neuroprotection; Neuroprotective Agents; Pregnancy; Premature Birth; Prenatal Care | 2021 |
Oxidative stress - Related spontaneous preterm delivery challenges in causality determination, prevention and novel strategies in reduction of the sequelae.
Topics: Acetylcysteine; Amniotic Fluid; Biomarkers; Clinical Trials as Topic; Female; Humans; Infant; Infant Mortality; Infant, Newborn; Infant, Premature; Isoprostanes; Magnesium Sulfate; Oxidative Stress; Placenta; Pregnancy; Premature Birth; Protective Agents; Steroids | 2019 |
Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour.
Topics: Female; Humans; Magnesium Chloride; Magnesium Compounds; Magnesium Oxide; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy; Premature Birth; Randomized Controlled Trials as Topic; Ritodrine; Terbutaline; Tocolysis; Tocolytic Agents | 2013 |
What do we know about tocolytic effectiveness and how do we use this information in guidelines? A comparison of evidence grading.
Topics: Adrenergic beta-Agonists; Attitude of Health Personnel; Calcium Channel Blockers; Evidence-Based Medicine; Glucocorticoids; Humans; Indomethacin; Lung; Magnesium Sulfate; Nitric Oxide Donors; Practice Guidelines as Topic; Premature Birth; Research Design; Surveys and Questionnaires; Tocolytic Agents; Vasotocin | 2013 |
Maternal adverse effects of different antenatal magnesium sulphate regimens for improving maternal and infant outcomes: a systematic review.
Topics: Administration, Intravenous; Anticonvulsants; Eclampsia; Female; Humans; Injections, Intramuscular; Magnesium Sulfate; Pregnancy; Premature Birth; Withholding Treatment | 2013 |
Tocolysis for preterm labor: expert opinion.
Topics: Anti-Bacterial Agents; Bed Rest; Calcium Channel Blockers; Cervical Length Measurement; Contraindications; Cyclooxygenase Inhibitors; Drug Approval; Female; Fenoterol; Fetal Membranes, Premature Rupture; Hexoprenaline; Humans; Infant, Newborn; Kalanchoe; Labor Stage, First; Magnesium Sulfate; Nitric Oxide Donors; Obstetric Labor, Premature; Phytotherapy; Pregnancy; Premature Birth; Progesterone; Progestins; Receptors, Oxytocin; Tocolysis; Tocolytic Agents; Ultrasonography, Prenatal | 2014 |
A moving line in the sand: a review of obstetric management surrounding periviability.
Topics: Adrenal Cortex Hormones; Cerebral Palsy; Cesarean Section; Directive Counseling; Female; Fetal Membranes, Premature Rupture; Humans; Infant, Extremely Premature; Magnesium Sulfate; Patient Education as Topic; Patient Participation; Pregnancy; Premature Birth | 2014 |
Magnesium sulphate for preventing preterm birth in threatened preterm labour.
Topics: Female; Fetal Death; Humans; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy; Premature Birth; Randomized Controlled Trials as Topic; Tocolytic Agents; Treatment Outcome | 2014 |
The use of intravenous magnesium in non-preeclamptic pregnant women: fetal/neonatal neuroprotection.
Topics: Administration, Intravenous; Australia; Canada; Cerebral Palsy; Female; Fetus; Humans; Infant, Newborn; Magnesium; Magnesium Sulfate; Neuroprotective Agents; Obstetric Labor, Premature; Pre-Eclampsia; Pregnancy; Premature Birth; Risk Assessment | 2015 |
Preterm labor: approach to decreasing complications of prematurity.
Topics: Adrenal Cortex Hormones; Adult; Cerebral Palsy; Cesarean Section; Female; Humans; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy; Premature Birth; Prognosis; Tocolytic Agents | 2015 |
Cyclo-oxygenase (COX) inhibitors for treating preterm labour.
Topics: Calcium Channel Blockers; Cyclooxygenase Inhibitors; Female; Humans; Indomethacin; Magnesium Sulfate; Pregnancy; Premature Birth; Randomized Controlled Trials as Topic; Tocolytic Agents | 2015 |
Different treatment regimens of magnesium sulphate for tocolysis in women in preterm labour.
Topics: Bone Diseases, Metabolic; Female; Fetal Death; Fractures, Bone; Humans; Hypocalcemia; Infant; Infant Death; Infant, Newborn; Injections, Intravenous; Magnesium Sulfate; Obstetric Labor, Premature; Perinatal Death; Pregnancy; Premature Birth; Randomized Controlled Trials as Topic; Tocolysis; Tocolytic Agents | 2015 |
Perinatal Neuroprotection for Extremely Preterm Infants.
Topics: Adrenal Cortex Hormones; Brain Injuries; Female; Humans; Infant, Extremely Premature; Infant, Newborn; Magnesium Sulfate; Neuroprotection; Parturition; Postnatal Care; Practice Guidelines as Topic; Pregnancy; Premature Birth; Prenatal Care; Randomized Controlled Trials as Topic | 2016 |
Tocolysis for Acute Preterm Labor: Where Have We Been, Where Are We Now, and Where are We Going?
Topics: Adrenergic beta-Agonists; Calcium Channel Blockers; Cyclooxygenase Inhibitors; Female; Humans; Infant, Newborn; Magnesium Sulfate; Nitric Oxide Donors; Obstetric Labor, Premature; Pregnancy; Premature Birth; Receptors, Oxytocin; Tocolysis; Tocolytic Agents | 2016 |
What we learned about the role of antenatal magnesium sulfate for the prevention of cerebral palsy.
Topics: Adult; Case-Control Studies; Cerebral Palsy; Double-Blind Method; Evidence-Based Medicine; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Pilot Projects; Pregnancy; Premature Birth; Prenatal Care; Randomized Controlled Trials as Topic; Treatment Outcome | 2016 |
Preventing newborn deaths due to prematurity.
Topics: Anti-Bacterial Agents; Breast Feeding; Continuous Positive Airway Pressure; Female; Fetal Membranes, Premature Rupture; Humans; Hypothermia; Incubators, Infant; Infant, Newborn; Infant, Premature; Kangaroo-Mother Care Method; Magnesium Sulfate; Obstetric Labor, Premature; Oxygen Inhalation Therapy; Perinatal Death; Pregnancy; Premature Birth; Pulmonary Surfactants; Tocolytic Agents | 2016 |
Practice Bulletin No. 169: Multifetal Gestations: Twin, Triplet, and Higher-Order Multifetal Pregnancies.
Topics: Adrenal Cortex Hormones; Chorion; Female; Fetal Death; Fetal Development; Gestational Age; Humans; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy; Pregnancy Complications; Pregnancy Reduction, Multifetal; Pregnancy, Multiple; Premature Birth; Tocolytic Agents; Ultrasonography, Prenatal | 2016 |
Practice Bulletin No. 172: Premature Rupture of Membranes.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Anticonvulsants; Cerclage, Cervical; Female; Fetal Membranes, Premature Rupture; Gestational Age; Humans; Magnesium Sulfate; Pregnancy; Premature Birth; Tocolytic Agents | 2016 |
[Neuroprotection for preterm infants with antenatal magnesium sulphate].
Topics: Adult; Cerebral Palsy; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Premature Birth | 2016 |
Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus.
Topics: Central Nervous System Diseases; Cerebral Palsy; Female; Fetal Death; Humans; Infant, Newborn; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Premature Birth; Prenatal Care; Randomized Controlled Trials as Topic | 2009 |
Magnesium sulfate for preterm labor and preterm birth.
Topics: Brain Diseases; Female; Humans; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Pregnancy; Premature Birth; Tocolytic Agents | 2009 |
Prematurity prevention: the role of acute tocolysis.
Topics: Acute Disease; Administration, Oral; Calcium Channel Blockers; Clinical Trials as Topic; Female; Humans; Magnesium Sulfate; Nifedipine; Obstetric Labor, Premature; Obstetrics; Oxytocin; Pregnancy; Premature Birth; Prostaglandin Antagonists; Tocolysis; Treatment Outcome | 2009 |
Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour.
Topics: Female; Humans; Magnesium Chloride; Magnesium Compounds; Magnesium Oxide; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy; Premature Birth; Randomized Controlled Trials as Topic; Ritodrine; Terbutaline; Tocolysis; Tocolytic Agents | 2010 |
Use of atosiban in a twin pregnancy with extremely preterm premature rupture in the membrane of one twin: a case report and literature review.
Topics: Adult; Female; Fetal Growth Retardation; Fetal Membranes, Premature Rupture; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Male; Pregnancy; Pregnancy, Multiple; Premature Birth; Reproductive Techniques, Assisted; Ritodrine; Tocolysis; Tocolytic Agents; Twins; Vasotocin | 2010 |
Impact of preterm PROM and its complications on long-term infant outcomes.
Topics: Adrenal Cortex Hormones; Cytokines; Female; Fetal Membranes, Premature Rupture; Genetic Predisposition to Disease; Gestational Age; Humans; Infant, Newborn; Inflammation; Magnesium Sulfate; Nervous System Diseases; Pregnancy; Premature Birth; Prognosis; Time Factors; Tocolytic Agents | 2011 |
Different magnesium sulphate regimens for neuroprotection of the fetus for women at risk of preterm birth.
Topics: Female; Humans; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Premature Birth; Risk | 2012 |
Antenatal magnesium individual participant data international collaboration: assessing the benefits for babies using the best level of evidence (AMICABLE).
Topics: Cerebral Palsy; Evidence-Based Medicine; Female; Fetal Death; Humans; Infant Mortality; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Pregnancy Outcome; Premature Birth; Prenatal Care; Randomized Controlled Trials as Topic; Risk Factors | 2012 |
Magnesium and the obstetric anaesthetist.
Topics: Adjuvants, Anesthesia; Analgesics; Anesthesia, Obstetrical; Anesthesiology; Cerebral Palsy; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium; Magnesium Sulfate; Neuroprotective Agents; Obstetric Labor, Premature; Pre-Eclampsia; Pregnancy; Premature Birth | 2013 |
Recent pharmacological advances in the treatment of preterm membrane rupture, labour and delivery.
Topics: Adrenergic beta-2 Receptor Agonists; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Calcium Channel Blockers; Female; Fetal Membranes, Premature Rupture; Humans; Magnesium Sulfate; Nitroglycerin; Obstetric Labor, Premature; Pregnancy; Premature Birth; Progesterone; Receptors, Oxytocin; Tocolytic Agents | 2004 |
Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus.
Topics: Central Nervous System Diseases; Cerebral Palsy; Female; Fetal Death; Humans; Infant, Newborn; Infant, Newborn, Diseases; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Premature Birth; Prenatal Care; Randomized Controlled Trials as Topic | 2007 |
Prevention of preterm delivery.
Topics: Adrenergic beta-Agonists; Biomarkers; Calcium Channel Blockers; Cyclooxygenase Inhibitors; Female; Humans; Magnesium Sulfate; Nitric Oxide Donors; Obstetric Labor, Premature; Pregnancy; Premature Birth; Receptors, Oxytocin; Risk Factors; Tocolysis; Tocolytic Agents; Uterine Contraction | 2007 |
Developments in the pharmacotherapeutic management of spontaneous preterm labor.
Topics: Female; Fetus; Glucocorticoids; Health Care Costs; Humans; Magnesium Sulfate; Nifedipine; Obstetric Labor, Premature; Pregnancy; Premature Birth; Tocolytic Agents; Vasotocin | 2008 |
26 trial(s) available for magnesium sulfate and Premature Birth
| Article | Year |
|---|---|
Adjuvant Treatment with Oral Dydrogesterone in the Prevention of Preterm Labor: A Randomized, Double-Blinded, Placebo-Controlled Trial.
Topics: Double-Blind Method; Dydrogesterone; Female; Humans; Infant, Newborn; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Premature Birth; Uterine Contraction | 2023 |
Prenatal Intravenous Magnesium at 30-34 Weeks' Gestation and Neurodevelopmental Outcomes in Offspring: The MAGENTA Randomized Clinical Trial.
Topics: Administration, Intravenous; Adult; Asian; Australia; Australian Aboriginal and Torres Strait Islander Peoples; Cerebral Palsy; Child, Preschool; Female; Gestational Age; Humans; Infant; Infant Mortality; Infant, Newborn; Magnesium Sulfate; Maori People; New Zealand; Pacific Island People; Pregnancy; Pregnancy Outcome; Premature Birth; Prenatal Care; White; Young Adult | 2023 |
PREPARE: protocol for a stepped wedge trial to evaluate whether a risk stratification model can reduce preterm deliveries among women with suspected or confirmed preterm pre-eclampsia.
Topics: Adrenal Cortex Hormones; Anticonvulsants; Antihypertensive Agents; Brazil; Delivery of Health Care; Disease Management; Female; Health Personnel; Humans; Magnesium Sulfate; Placenta Growth Factor; Pre-Eclampsia; Pregnancy; Premature Birth; Prenatal Care; Risk Assessment; Seizures; Vascular Endothelial Growth Factor Receptor-1 | 2019 |
Antenatal magnesium sulphate for the prevention of cerebral palsy in infants born preterm: a double-blind, randomised, placebo-controlled, multi-centre trial.
Topics: Adult; Cerebral Palsy; Denmark; Double-Blind Method; Female; Humans; Infant; Infant, Newborn; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Premature Birth; Prenatal Care; Severity of Illness Index | 2020 |
Prenatal Tobacco Exposure and Childhood Neurodevelopment among Infants Born Prematurely.
Topics: Cerebral Palsy; Child, Preschool; Female; Gestational Age; Humans; Infant; Infant Mortality; Infant, Newborn; Infant, Premature; Logistic Models; Magnesium Sulfate; Male; Multivariate Analysis; Pregnancy; Premature Birth; Risk Factors; Stillbirth; Tobacco Use; Vision Disorders | 2021 |
Magnesium sulfate for neuroprotection in the setting of chorioamnionitis.
Topics: Adult; Cerebral Palsy; Chorioamnionitis; Female; Humans; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Pregnancy Outcome; Premature Birth; Prenatal Care | 2018 |
Maternal obesity is associated with chorioamnionitis and earlier indicated preterm delivery among expectantly managed women with preterm premature rupture of membranes.
Topics: Adult; Cesarean Section; Chorioamnionitis; Female; Fetal Membranes, Premature Rupture; Humans; Infant, Newborn; Magnesium Sulfate; Obesity; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Premature Birth; Retrospective Studies; Time Factors | 2019 |
Effect of Cord Blood Magnesium Level at Birth on Non-neurologic Neonatal Outcomes.
Topics: Adult; Anticonvulsants; Bronchopulmonary Dysplasia; Cerebral Palsy; Enterocolitis, Necrotizing; Female; Fetal Blood; Humans; Infant, Newborn; Intellectual Disability; Magnesium; Magnesium Sulfate; Male; Outcome Assessment, Health Care; Pregnancy; Premature Birth; Retinopathy of Prematurity | 2019 |
Genetic Variation, Magnesium Sulfate Exposure, and Adverse Neurodevelopmental Outcomes Following Preterm Birth.
Topics: Case-Control Studies; Cerebral Palsy; Child, Preschool; Female; Genetic Variation; Gestational Age; Humans; Infant; Infant Mortality; Infant, Newborn; Infant, Premature, Diseases; Logistic Models; Magnesium Sulfate; Male; Neurodevelopmental Disorders; Neuroprotective Agents; Polymorphism, Single Nucleotide; Pregnancy; Premature Birth; Prenatal Care; Prenatal Exposure Delayed Effects; Psychomotor Disorders; Receptors, Interleukin-6; Stillbirth | 2018 |
Magnesium sulphate at 30 to 34 weeks' gestational age: neuroprotection trial (MAGENTA)--study protocol.
Topics: Blindness; Calcium Channel Blockers; Cerebral Palsy; Child Behavior; Child, Preschool; Deafness; Developmental Disabilities; Female; Gestational Age; Health Status; Humans; Infant; Infant Mortality; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Perinatal Mortality; Pregnancy; Premature Birth; Psychological Tests; Research Design; Stillbirth | 2013 |
Influence of antenatal magnesium sulfate application on cord blood levels of brain-derived neurotrophic factor in premature infants.
Topics: Administration, Intravenous; Adult; Biomarkers; Brain-Derived Neurotrophic Factor; Cerebral Palsy; Drug Administration Schedule; Enzyme-Linked Immunosorbent Assay; Female; Fetal Blood; Follow-Up Studies; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Pre-Eclampsia; Pregnancy; Premature Birth; Prenatal Care | 2014 |
Maternal adverse effects with different loading infusion rates of antenatal magnesium sulphate for preterm fetal neuroprotection: the IRIS randomised trial.
Topics: Blood Pressure; Brain Injuries; Cerebral Hemorrhage; Cerebral Palsy; Cesarean Section; Diastole; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Premature Birth; Respiratory Rate | 2014 |
Correlation between initial neonatal and early childhood outcomes following preterm birth.
Topics: Adult; Cerebral Palsy; Developmental Disabilities; Female; Health Status Indicators; Humans; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Pregnancy; Pregnancy Outcome; Premature Birth; Risk Factors; ROC Curve; Twins; Young Adult | 2014 |
Alterations in regulatory T cell subpopulations seen in preterm infants.
Topics: Adult; Analgesics; Anti-Bacterial Agents; Female; Fetal Blood; Flow Cytometry; Humans; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Male; Platelet Endothelial Cell Adhesion Molecule-1; Premature Birth; Steroids; T-Lymphocytes, Regulatory | 2014 |
Fetomaternal outcome in severe preeclamptic women undergoing emergency cesarean section under either general or spinal anesthesia.
Topics: Adolescent; Adult; Anesthesia, General; Anesthesia, Spinal; Anticonvulsants; Antihypertensive Agents; Apgar Score; Cesarean Section; Female; Fetal Mortality; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Labetalol; Magnesium Sulfate; Maternal Mortality; Methyldopa; Pre-Eclampsia; Pregnancy; Premature Birth; Prospective Studies; Seizures; Severity of Illness Index; Treatment Outcome; Young Adult | 2014 |
The association of cord serum cytokines with neurodevelopmental outcomes.
Topics: Adult; Case-Control Studies; Cerebral Palsy; Child Development; Child, Preschool; Cytokines; Developmental Disabilities; Female; Fetal Blood; Humans; Infant; Infant, Newborn; Infant, Premature; Interleukin-1beta; Interleukin-8; Logistic Models; Magnesium Sulfate; Pregnancy; Premature Birth; Prognosis; Tocolytic Agents; Tumor Necrosis Factor-alpha; Young Adult | 2015 |
Association of duration of neuroprotective magnesium sulfate infusion with neonatal and maternal outcomes.
Topics: Adult; Apgar Score; Birth Weight; Cerebral Palsy; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Gestational Age; Humans; Infant; Infant Mortality; Infant, Newborn; Infusions, Intravenous; Logistic Models; Magnesium Sulfate; Male; Maternal Welfare; Neuroprotective Agents; Odds Ratio; Pregnancy; Pregnancy Outcome; Premature Birth; Prenatal Care; Prospective Studies; Risk Assessment; Treatment Outcome | 2014 |
School-age outcomes of very preterm infants after antenatal treatment with magnesium sulfate vs placebo.
Topics: Cerebral Palsy; Child Development; Cognition Disorders; Female; Follow-Up Studies; Humans; Infant Mortality; Infant, Extremely Premature; Infant, Newborn; Magnesium Sulfate; Male; Motor Skills Disorders; Neuroprotective Agents; Pregnancy; Premature Birth; Prenatal Care; Treatment Outcome | 2014 |
Does magnesium exposure affect neonatal resuscitation?
Topics: Apgar Score; Cerebral Palsy; Female; Humans; Hypotension; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Linear Models; Magnesium Sulfate; Muscle Hypotonia; Neuroprotective Agents; Pregnancy; Premature Birth; Prenatal Exposure Delayed Effects; Resuscitation | 2015 |
Magnesium sulfate, chorioamnionitis, and neurodevelopment after preterm birth.
Topics: Adult; Cerebral Palsy; Chorioamnionitis; Female; Humans; Infant; Infant Mortality; Infant, Premature, Diseases; Magnesium Sulfate; Male; Neurodevelopmental Disorders; Neuroprotective Agents; Pregnancy; Premature Birth; Prenatal Care; Prenatal Exposure Delayed Effects; Psychomotor Disorders; Stillbirth | 2016 |
Proximity of magnesium exposure to delivery and neonatal outcomes.
Topics: Adult; Cerebral Palsy; Delivery, Obstetric; Female; Humans; Infant, Newborn; Magnesium Sulfate; Obstetric Labor, Premature; Odds Ratio; Placebos; Pregnancy; Premature Birth; Risk Factors; Time Factors | 2016 |
Prolonged latency of preterm prelabour rupture of membranes and neurodevelopmental outcomes: a secondary analysis.
Topics: Adult; Body Mass Index; Cerebral Palsy; Delivery, Obstetric; Female; Fetal Membranes, Premature Rupture; Gestational Age; Humans; Infant, Newborn; Magnesium Sulfate; Parturition; Pregnancy; Premature Birth; Risk Factors; Tocolytic Agents; United States | 2016 |
Association of Maternal Obesity with Child Cerebral Palsy or Death.
Topics: Adult; Cerebral Palsy; Cesarean Section; Female; Gestational Age; Humans; Infant; Infant Mortality; Infant, Newborn; Logistic Models; Magnesium Sulfate; Male; Neuroprotective Agents; Obesity; Perinatal Death; Pregnancy; Pregnancy Complications; Premature Birth; Retrospective Studies; Severity of Illness Index; United States; Young Adult | 2017 |
The effect of magnesium sulfate treatment on blood biochemistry and bleeding time in patients with severe preeclampsia.
Topics: Anticonvulsants; Biochemistry; Birth Weight; Bleeding Time; Blood Chemical Analysis; Blood Pressure; Cross-Sectional Studies; Female; Fibrinolytic Agents; Humans; Infant Mortality; Infant, Newborn; Magnesium Sulfate; Pre-Eclampsia; Pregnancy; Premature Birth; Severity of Illness Index | 2010 |
Randomized controlled trial of magnesium sulfate in women at risk of preterm delivery-neonatal cardiovascular effects.
Topics: Cerebral Palsy; Echocardiography; Female; Hemodynamics; Humans; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Premature Birth; Regional Blood Flow; Tocolytic Agents; Vena Cava, Superior; Ventricular Function, Right | 2012 |
Benefit of magnesium sulfate given before very preterm birth to protect infant brain.
Topics: Brain Diseases; Delivery, Obstetric; Developmental Disabilities; Female; Follow-Up Studies; Gestational Age; Humans; Infant, Newborn; Infant, Very Low Birth Weight; Infusions, Intravenous; Magnesium Sulfate; Male; Odds Ratio; Pregnancy; Premature Birth; Probability; Reference Values; Survival Analysis; Treatment Outcome | 2008 |
84 other study(ies) available for magnesium sulfate and Premature Birth
| Article | Year |
|---|---|
Antenatal magnesium sulphate for preventing cerebral palsy: An economic evaluation of the impact of a quality improvement program.
Topics: Cerebral Palsy; Child; Cost-Benefit Analysis; Female; Humans; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Premature Birth; Quality Improvement | 2022 |
Management and outcomes of extreme preterm birth.
Topics: Adult; Decision Making, Shared; Female; Humans; Infant, Extremely Premature; Infant, Newborn; Infant, Premature, Diseases; Intensive Care, Neonatal; Magnesium Sulfate; Male; Neurodevelopmental Disorders; Perinatal Care; Peripartum Period; Pregnancy; Premature Birth | 2022 |
Effect of antenatal magnesium sulphate on MRI biomarkers of white matter development at term equivalent age: The MagNUM Study.
Topics: Australia; Biomarkers; Cohort Studies; Female; Humans; Infant; Infant, Newborn; Magnesium Sulfate; Magnetic Resonance Imaging; Parturition; Pregnancy; Premature Birth; White Matter | 2022 |
Maternal and fetal serum concentrations of magnesium after administration of a 6-g bolus dose of magnesium sulfate (MgSO
Topics: Cerebral Palsy; Female; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Magnesium; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Premature Birth; Prenatal Care | 2022 |
Impact of prolonged use of adjuvant tocolytics after cervical cerclage on late abortion and premature delivery.
Topics: Cerclage, Cervical; Child; Female; Gestational Age; Humans; Infant; Magnesium Sulfate; Pregnancy; Pregnancy Outcome; Pregnancy, Prolonged; Premature Birth; Quality of Life; Retrospective Studies; Tocolytic Agents; Uterine Cervical Incompetence | 2023 |
Long-term effects of prophylactic MgSO
Topics: Animals; Brain; Female; Humans; Infant, Newborn; Inflammation; Lipopolysaccharides; Magnesium Sulfate; Pregnancy; Premature Birth; Rodentia | 2023 |
Magnesium sulphate reduces tertiary gliosis but does not improve EEG recovery or white or grey matter cell survival after asphyxia in preterm fetal sheep.
Topics: Animals; Asphyxia; Cell Survival; Electroencephalography; Female; Gliosis; Gray Matter; Humans; Hypoxia; Infant, Newborn; Ischemia; Magnesium Sulfate; Premature Birth; Sheep; White Matter | 2023 |
Management of preterm birth using protocols in a low resource setting.
Topics: Child; Female; Humans; Infant, Newborn; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy; Premature Birth; Prenatal Care; Tocolytic Agents | 2023 |
A follow up on the feasibility after national implementation of magnesium sulfate for neuroprotection prior to preterm birth.
Topics: Adult; Cerebral Palsy; Child; Feasibility Studies; Female; Follow-Up Studies; Humans; Infant, Newborn; Magnesium Sulfate; Neuroprotection; Neuroprotective Agents; Pregnancy; Premature Birth; Prenatal Care; Young Adult | 2023 |
Neuroprotective effect of magnesium sulfate in premature infants. Analysis after establishing an antenatal administration protocol in a tertiary care hospital.
Topics: Cerebral Palsy; Enterocolitis, Necrotizing; Female; Humans; Infant; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Neuroprotective Agents; Parturition; Pregnancy; Premature Birth; Retrospective Studies; Tertiary Care Centers | 2023 |
Antenatal Magnesium Sulfate Is Not Associated With Improved Long-Term Neurodevelopment and Growth in Very Low Birth Weight Infants.
Topics: Female; Humans; Infant; Infant, Newborn; Infant, Very Low Birth Weight; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Premature Birth; Prenatal Care | 2023 |
Eclampsia in Australia and New Zealand: A prospective population-based study.
Topics: Australia; Eclampsia; Female; Humans; Infant, Newborn; Magnesium Sulfate; New Zealand; Pregnancy; Premature Birth; Prospective Studies | 2020 |
Factors contributing to favourable neonatal outcomes in early-onset severe preeclampsia.
Topics: Adult; Birth Weight; Clinical Protocols; Female; Fetal Growth Retardation; Gestational Age; Humans; Infant, Newborn; Logistic Models; Magnesium Sulfate; Odds Ratio; Pre-Eclampsia; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, Third; Premature Birth; Treatment Outcome | 2021 |
The Effect of Antenatal Neuroprotective Magnesium Sulfate Treatment on Cerebral Oxygenation in Preterm Infants.
Topics: Brain; Cerebral Intraventricular Hemorrhage; Female; Humans; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Male; Neuroprotection; Oxygen; Oxygen Saturation; Pregnancy; Premature Birth; Prenatal Care; Prospective Studies; Spectroscopy, Near-Infrared | 2021 |
Successful Treatment of Preterm Labor in Association with Acute COVID-19 Infection.
Topics: Antibiotic Prophylaxis; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Glucocorticoids; Humans; Infant, Newborn; Magnesium Sulfate; Pandemics; Pneumonia, Viral; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Premature Birth; SARS-CoV-2; Streptococcal Infections; Tocolytic Agents | 2020 |
Magnesium sulphate for prevention of cerebral palsy: if not now, when?
Topics: Cerebral Palsy; Double-Blind Method; Female; Humans; Infant; Infant, Newborn; Magnesium Sulfate; Parturition; Pregnancy; Premature Birth | 2020 |
Re: Antenatal magnesium sulphate for the prevention of cerebral palsy in infants born preterm: a double-blind, randomised, placebo-controlled, multi-centre trial: At which gestational ages should magnesium sulphate be given to women at risk of preterm bir
Topics: Cerebral Palsy; Double-Blind Method; Female; Gestational Age; Humans; Infant; Infant, Newborn; Magnesium Sulfate; Parturition; Pregnancy; Premature Birth | 2020 |
COVID-19 infection during pregnancy: fetus as a patient deserves more attention.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Delivery, Obstetric; Female; Fetal Therapies; Humans; Infectious Disease Transmission, Vertical; Magnesium Sulfate; Neuroprotective Agents; Pandemics; Pneumonia, Viral; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; Premature Birth; Prenatal Care; SARS-CoV-2 | 2020 |
Authors' reply re: Antenatal magnesium sulphate for the prevention of cerebral palsy in infants born preterm: a double-blind, randomised, placebo-controlled, multi-centre trial: Time range for treatment with magnesium sulphate.
Topics: Cerebral Palsy; Double-Blind Method; Female; Gestational Age; Humans; Infant; Infant, Newborn; Magnesium Sulfate; Parturition; Pregnancy; Premature Birth | 2020 |
Antenatal Magnesium Sulfate and Preeclampsia Differentially Affect Neonatal Cerebral Oxygenation.
Topics: Female; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Pre-Eclampsia; Pregnancy; Premature Birth | 2020 |
Antenatal magnesium sulfate treatment and risk of necrotizing enterocolitis in preterm infants born at less than 32 weeks of gestation.
Topics: Cohort Studies; Eclampsia; Enterocolitis, Necrotizing; Female; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Maternal-Fetal Exchange; Negative Results; Pregnancy; Premature Birth; Prenatal Care; Prenatal Exposure Delayed Effects; Retrospective Studies; Risk | 2020 |
The impact of the definition of preeclampsia on disease diagnosis and outcomes: a retrospective cohort study.
Topics: Acute Kidney Injury; Adult; Anticonvulsants; Antihypertensive Agents; Cesarean Section; Cohort Studies; Disseminated Intravascular Coagulation; Eclampsia; Female; Fetal Growth Retardation; Gestational Age; Headache; Hemolysis; Humans; Hypertension, Pregnancy-Induced; Intensive Care Units; Intensive Care Units, Neonatal; Labor, Induced; Liver Diseases; Logistic Models; Magnesium Sulfate; Nervous System Diseases; Perinatal Death; Postpartum Hemorrhage; Pre-Eclampsia; Pregnancy; Premature Birth; Proteinuria; Pulmonary Edema; Retrospective Studies; Severity of Illness Index; Stroke; Thrombocytopenia; Vision Disorders; Young Adult | 2021 |
Neuroprotective magnesium sulfate administration increases maternal Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio and Systemic Immune-Inflammation Index.
Topics: Biomarkers; Blood Cell Count; Blood Platelets; Female; Humans; Inflammation; Lymphocyte Count; Lymphocytes; Magnesium Sulfate; Neuroprotection; Neutrophils; Platelet Count; Pregnancy; Premature Birth; Retrospective Studies | 2021 |
Translating antenatal magnesium sulphate neuroprotection for infants born <28 weeks' gestation into practice: A geographical cohort study.
Topics: Cerebral Palsy; Child; Child, Preschool; Cohort Studies; Female; Gestational Age; Humans; Infant; Magnesium Sulfate; Neuroprotection; Neuroprotective Agents; Parturition; Pregnancy; Premature Birth; Victoria | 2021 |
Cerebral Palsy in Very Preterm Infants: A Nine-Year Prospective Study in a French Population-Based Tertiary Center.
Topics: Cerebral Palsy; Child, Preschool; Female; France; Humans; Infant, Premature; Longitudinal Studies; Magnesium Sulfate; Male; Neuroprotective Agents; Pregnancy; Premature Birth; Prenatal Care; Prospective Studies; Tocolytic Agents | 2021 |
Antenatal magnesium sulfate to prevent cerebral palsy.
Topics: Calcium Channel Blockers; Cerebral Palsy; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Pregnancy; Premature Birth | 2022 |
Adherence to uptake of magnesium sulphate for neuroprotection in preterm births <30 weeks at Christchurch Hospital.
Topics: Cerebral Palsy; Female; Humans; Infant, Newborn; Magnesium Sulfate; Neuroprotective Agents; New Zealand; Pregnancy; Premature Birth; Retrospective Studies | 2017 |
Quality measures in high-risk pregnancies: Executive Summary of a Cooperative Workshop of the Society for Maternal-Fetal Medicine, National Institute of Child Health and Human Development, and the American College of Obstetricians and Gynecologists.
Topics: Antibiotic Prophylaxis; Aspirin; Cesarean Section; Congresses as Topic; Female; Fetal Growth Retardation; Genetic Counseling; Genetic Testing; Glucocorticoids; Humans; Hypertension, Pregnancy-Induced; Magnesium Sulfate; National Institute of Child Health and Human Development (U.S.); Pregnancy; Pregnancy Complications; Pregnancy, High-Risk; Premature Birth; Prenatal Diagnosis; Quality of Health Care; Sepsis; Societies, Medical; United States; Vaginal Birth after Cesarean; Venous Thromboembolism | 2017 |
No. 347-Obstetric Management at Borderline Viability.
Topics: Adrenal Cortex Hormones; Delivery, Obstetric; Female; Fetal Viability; Gestational Age; Humans; Infant, Premature, Diseases; Magnesium Sulfate; Patient Transfer; Pregnancy; Premature Birth | 2017 |
Antenatal magnesium sulphate administration for fetal neuroprotection: a French national survey.
Topics: Anesthesiology; Calcium Channel Blockers; France; Gestational Age; Hospitals, Maternity; Hospitals, University; Humans; Infant, Premature; Magnesium Sulfate; Neonatology; Neuroprotective Agents; Obstetrics; Practice Guidelines as Topic; Practice Patterns, Physicians'; Premature Birth; Surveys and Questionnaires; Tertiary Care Centers | 2017 |
Antenatal magnesium for preterm delivery reduces risk of cerebral palsy among surviving very preterm infants.
Topics: Cerebral Palsy; Female; Humans; Infant; Infant, Newborn; Infant, Premature; Magnesium; Magnesium Sulfate; Pregnancy; Premature Birth | 2018 |
Magnesium sulfate differentially modulates fetal membrane inflammation in a time-dependent manner.
Topics: Caspase 1; Chorioamnionitis; Cytokines; Extraembryonic Membranes; Female; Humans; Inflammation; Interleukin-1beta; Magnesium Sulfate; Pregnancy; Premature Birth; Time Factors; Up-Regulation | 2018 |
[Antenatal management in case of preterm premature rupture of membranes before fetal viability: CNGOF Preterm Premature Rupture of Membranes Guidelines].
Topics: Adrenal Cortex Hormones; Amniocentesis; Antibiotic Prophylaxis; Female; Fetal Death; Fetal Membranes, Premature Rupture; Fetal Viability; France; Gestational Age; Humans; Infant, Premature; Magnesium Sulfate; MEDLINE; Pregnancy; Premature Birth; Prognosis; Tocolysis | 2018 |
Comparison of Cerebral Palsy Severity Between 2 Eras of Antenatal Magnesium Use.
Topics: Cerebral Palsy; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infant, Newborn; Logistic Models; Magnesium Sulfate; Male; Neuroprotective Agents; Ohio; Pregnancy; Premature Birth; Prenatal Care; Retrospective Studies; Severity of Illness Index; Treatment Outcome | 2019 |
Sex-Specific Genetic Susceptibility to Adverse Neurodevelopmental Outcome in Offspring of Pregnancies at Risk of Early Preterm Delivery.
Topics: Case-Control Studies; Cerebral Palsy; Female; Genetic Predisposition to Disease; Humans; Infant; Interleukin-6; Logistic Models; Magnesium Sulfate; Male; Neurodevelopmental Disorders; Polymorphism, Single Nucleotide; Pregnancy; Premature Birth; Psychomotor Disorders; Sex Factors; Tocolytic Agents | 2020 |
No. 376-Magnesium Sulphate for Fetal Neuroprotection.
Topics: Australia; Female; Humans; Infant, Premature; Magnesium Sulfate; Neuroprotective Agents; Obstetric Labor, Premature; Practice Guidelines as Topic; Pregnancy; Premature Birth; Prenatal Care; Societies, Medical | 2019 |
Survey on use of antenatal magnesium sulphate for fetal neuroprotection prior to preterm birth in Australia and New Zealand - Ongoing barriers and enablers.
Topics: Australia; Cerebral Palsy; Female; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Magnesium Sulfate; Neuroprotective Agents; New Zealand; Pregnancy; Premature Birth; Surveys and Questionnaires; Tocolytic Agents | 2020 |
Magnesium sulfate increases intracellular magnesium reducing inflammatory cytokine release in neonates.
Topics: Cell Line; Cells, Cultured; Cytokines; Fetal Blood; Humans; Infant, Newborn; Inflammation; Interleukin-6; Leukocytes, Mononuclear; Magnesium; Magnesium Sulfate; Monocytes; Premature Birth; Tumor Necrosis Factor-alpha | 2013 |
Magnesium sulphate for the prevention of cerebral palsy in Australia and New Zealand.
Topics: Australia; Cerebral Palsy; Female; Fetus; Humans; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Neuroprotective Agents; New Zealand; Pregnancy; Premature Birth | 2013 |
Magnesium sulphate for fetal neuroprotection: a cost-effectiveness analysis.
Topics: Cerebral Palsy; Cost Savings; Cost-Benefit Analysis; Decision Trees; Drug Costs; Female; Fetus; Gestational Age; Health Care Costs; Humans; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Premature Birth; Prenatal Care; Quality of Life; Quality-Adjusted Life Years; Risk Assessment | 2013 |
Working to improve survival and health for babies born very preterm: the WISH project protocol.
Topics: Australia; Cerebral Palsy; Child, Preschool; Evidence-Based Medicine; Female; Gestational Age; Guideline Adherence; Hospitals, Maternity; Humans; Infant; Infant, Extremely Premature; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Medical Audit; Neuroprotective Agents; New Zealand; Practice Guidelines as Topic; Pregnancy; Premature Birth; Prenatal Care; Prospective Studies; Research Design | 2013 |
Fetal pharmacotherapy 3: magnesium sulfate.
Topics: Cerebral Palsy; Female; Humans; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Pregnancy; Premature Birth; Tocolytic Agents | 2013 |
Effect of magnesium sulfate and nifedipine on the risk of developing pulmonary edema in preterm births.
Topics: Adult; Azithromycin; Case-Control Studies; Drug Synergism; Erythromycin; Female; Humans; Infant, Newborn; Logistic Models; Magnesium Sulfate; Nifedipine; Obstetric Labor, Premature; Pregnancy; Pregnancy Complications; Pregnancy, Multiple; Premature Birth; Pulmonary Edema; Retrospective Studies; Risk Factors; Tocolysis; Tocolytic Agents; Young Adult | 2014 |
Acute respiratory failure in a 35-year-old woman following preterm vaginal delivery.
Topics: Adrenal Cortex Hormones; Adult; Chorioamnionitis; Female; Humans; Magnesium Sulfate; Pregnancy; Premature Birth; Puerperal Disorders; Pulmonary Edema; Respiratory Distress Syndrome; Tocolytic Agents | 2014 |
Disparity in post-treatment maternal circulating magnesium sulfate levels between twin and singleton gestation: Is this the missing link between plurality and adverse outcome?
Topics: Adult; Case-Control Studies; Cerebral Palsy; Female; Humans; Infant, Newborn; Infusions, Intravenous; Magnesium; Magnesium Deficiency; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Pregnancy Outcome; Pregnancy, Twin; Premature Birth; Regression Analysis | 2015 |
A prospective audit of the adherence to a new magnesium sulphate guideline for the neuroprotection of infants born less than 30 weeks' gestation.
Topics: Adult; Anticonvulsants; Cerebral Palsy; Female; Gestational Age; Guideline Adherence; Hospitals, Public; Humans; Magnesium Sulfate; Medical Audit; New Zealand; Practice Guidelines as Topic; Pregnancy; Premature Birth; Prospective Studies; Young Adult | 2015 |
The neuroprotective effect of magnesium sulfate in preterm fetal mice.
Topics: Animals; Brain; Cells, Cultured; Cerebral Palsy; Cytokines; Disease Models, Animal; DNA-Binding Proteins; Encephalitis; Female; Humans; Inflammation Mediators; Magnesium Sulfate; Mice; Nerve Tissue Proteins; Neuroprotective Agents; Nuclear Proteins; Pregnancy; Premature Birth; S100 Calcium Binding Protein beta Subunit; Tocolytic Agents | 2015 |
Magnesium sulfate for prevention of preterm birth.
Topics: Female; Humans; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy; Premature Birth; Tocolytic Agents | 2015 |
Antenatal magnesium sulfate and neurodevelopmental outcome of preterm infants born to preeclamptic mothers.
Topics: Adult; Brain; Child Development; Female; Humans; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Male; Pre-Eclampsia; Pregnancy; Pregnancy Outcome; Premature Birth; Prenatal Care; Prenatal Exposure Delayed Effects; Retrospective Studies | 2016 |
Use and attitudes of obstetricians toward 3 high-risk interventions in MFMU Network hospitals.
Topics: Adrenal Cortex Hormones; Adult; Attitude of Health Personnel; Data Collection; Evidence-Based Medicine; Female; Humans; Magnesium Sulfate; Neuroprotective Agents; Practice Patterns, Physicians'; Pregnancy; Premature Birth; Prenatal Care; Progesterone; Progestins; Recurrence; United States | 2015 |
Nonreceipt of antenatal magnesium sulphate for fetal neuroprotection at the Women's and Children's Hospital, Adelaide 2010-2013.
Topics: Adult; Cerebral Palsy; Cesarean Section; Female; Fetal Distress; Gestational Age; Guideline Adherence; Hospitals, Maternity; Hospitals, Pediatric; Humans; Labor Onset; Magnesium Sulfate; Medical Audit; Parity; Practice Guidelines as Topic; Pregnancy; Premature Birth; South Australia; Tocolytic Agents; Young Adult | 2015 |
Mode of delivery at periviability and early childhood neurodevelopment.
Topics: Adult; Calcium Channel Blockers; Cerebral Palsy; Cesarean Section; Child Development; Child, Preschool; Cognition; Cohort Studies; Delivery, Obstetric; Female; Fetal Viability; Humans; Infant, Extremely Premature; Longitudinal Studies; Magnesium Sulfate; Motor Skills; Pregnancy; Premature Birth; Prospective Studies; Regression Analysis; Young Adult | 2015 |
Maternal obesity and neuroprotective magnesium sulfate.
Topics: Adult; Case-Control Studies; Cerebral Palsy; Cohort Studies; Female; Gestational Age; Humans; Infant, Newborn; Logistic Models; Magnesium Sulfate; Neuroprotective Agents; Obesity; Obesity, Morbid; Perinatal Death; Pregnancy; Pregnancy Complications; Premature Birth; Prospective Studies; Treatment Outcome; Young Adult | 2015 |
Update on the use of magnesium sulphate for fetal neuroprotection in preterm birth.
Topics: Brain Diseases; Fetal Diseases; Humans; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Practice Guidelines as Topic; Premature Birth | 2015 |
Barriers and enablers to implementing antenatal magnesium sulphate for fetal neuroprotection guidelines: a study using the theoretical domains framework.
Topics: Attitude of Health Personnel; Cerebral Palsy; Clinical Competence; Female; Guideline Adherence; Humans; Infant, Extremely Premature; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Midwifery; Neonatology; Neuroprotective Agents; Obstetrics; Perinatal Death; Practice Guidelines as Topic; Pregnancy; Premature Birth; Reminder Systems; South Australia; Time Factors | 2015 |
Effect of obesity on neonatal outcomes in pregnancies with preterm premature rupture of membranes.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Birth Weight; Case-Control Studies; Cerebral Hemorrhage; Chorioamnionitis; Diabetes Mellitus; Enterocolitis, Necrotizing; Female; Fetal Membranes, Premature Rupture; Gestational Age; Humans; Indomethacin; Infant, Extremely Premature; Infant, Newborn; Infant, Premature; Logistic Models; Magnesium Sulfate; Male; Multivariate Analysis; Obesity; Perinatal Death; Pregnancy; Pregnancy Complications; Premature Birth; Respiratory Distress Syndrome, Newborn; Risk Factors; Sepsis; Tocolytic Agents; Young Adult | 2016 |
Magnesium sulphate can prolong pregnancy in patients with severe early-onset preeclampsia.
Topics: Acute Disease; Adult; Disease Progression; Female; Gestational Age; Historically Controlled Study; Humans; Magnesium Sulfate; Platelet Count; Pre-Eclampsia; Pregnancy; Pregnancy Outcome; Premature Birth; Retrospective Studies; Statistics, Nonparametric; Tocolytic Agents | 2016 |
Connect the Dots...
Topics: Adrenal Cortex Hormones; Attitude of Health Personnel; Balloon Occlusion; Blood Loss, Surgical; Cesarean Section; Evidence-Based Medicine; Female; Humans; Magnesium Sulfate; Placenta Accreta; Practice Patterns, Physicians'; Pregnancy; Premature Birth; Progesterone | 2015 |
Magnesium sulphate for fetal neuroprotection: benefits and challenges of a systematic knowledge translation project in Canada.
Topics: Canada; Cerebral Palsy; Female; Guideline Adherence; Health Personnel; Humans; Infant, Newborn; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Premature Birth; Societies, Medical; Translational Research, Biomedical | 2015 |
Short-term morbidities and neurodevelopmental outcomes in preterm infants exposed to magnesium sulphate treatment.
Topics: Adult; Case-Control Studies; Female; Follow-Up Studies; Gestational Age; Humans; Infant, Premature; Intensive Care Units, Neonatal; Israel; Linear Models; Magnesium Sulfate; Male; Morbidity; Motor Skills Disorders; Multivariate Analysis; Neurodevelopmental Disorders; Pregnancy; Premature Birth; Prenatal Care; Retrospective Studies; Risk Assessment; Statistics, Nonparametric; Time Factors | 2016 |
Biases in secondary analyses of randomised trials: recognition, correction, and implications.
Topics: Bias; Chorioamnionitis; Female; Humans; Infant, Newborn; Magnesium Sulfate; Pregnancy; Premature Birth | 2016 |
Re: Magnesium sulphate, chorioamnionitis, and neurodevelopment after preterm birth.
Topics: Chorioamnionitis; Female; Humans; Infant, Newborn; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy; Premature Birth; Tocolytic Agents | 2016 |
Authors' reply re: Magnesium sulphate, chorioamnionitis, and neurodevelopment after preterm birth.
Topics: Chorioamnionitis; Female; Humans; Infant, Newborn; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy; Premature Birth; Tocolytic Agents | 2016 |
Observations of fetal brain activity via non-invasive magnetoencephalography following administration of magnesium sulfate for neuroprotection in preterm labor.
Topics: Anticonvulsants; Brain; Brain Waves; Cerebral Palsy; Female; Humans; Magnesium Sulfate; Magnetoencephalography; Neuroprotective Agents; Obstetric Labor, Premature; Pregnancy; Premature Birth | 2016 |
Introducing a preterm care bundle: magnesium sulphate can be the fifth component.
Topics: Female; Humans; Magnesium Sulfate; Patient Care Bundles; Pregnancy; Premature Birth | 2016 |
Comparison of perinatal outcomes between long-term and short-term use of tocolytic agent: a historical cohort study in a single perinatal hospital.
Topics: Adult; Cohort Studies; Female; Gestational Age; Humans; Magnesium Sulfate; Pregnancy; Pregnancy Outcome; Premature Birth; Ritodrine; Tocolytic Agents; Treatment Outcome | 2016 |
Use of magnesium sulfate before 32 weeks of gestation: a European population-based cohort study.
Topics: Adult; Calcium Channel Blockers; Cohort Studies; Eclampsia; Europe; Evidence-Based Medicine; Female; Gestational Age; Guideline Adherence; HELLP Syndrome; Humans; Magnesium Sulfate; Practice Patterns, Physicians'; Pre-Eclampsia; Pregnancy; Pregnancy Trimester, Second; Premature Birth; Severity of Illness Index; Young Adult | 2017 |
Antenatal magnesium sulfate for neuroprotection before preterm birth?
Topics: Cerebral Palsy; Female; Humans; Infant Mortality; Infant, Newborn; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy; Premature Birth; Tocolytic Agents | 2008 |
Do neonatal outcomes differ depending on the cause of preterm birth? A comparison between spontaneous birth and iatrogenic delivery for preeclampsia.
Topics: Adult; Anti-Bacterial Agents; Betamethasone; Case-Control Studies; Delivery, Obstetric; Drug Utilization; Female; Fetal Growth Retardation; Gestational Age; Glucocorticoids; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Intensive Care Units, Neonatal; Length of Stay; Magnesium Sulfate; Male; Pre-Eclampsia; Pregnancy; Premature Birth; Prospective Studies; Respiration, Artificial; Retrospective Studies; Tocolytic Agents | 2010 |
Magnesium sulfate for neuroprotection: what do we do now?
Topics: Cerebral Palsy; Female; Humans; Infant, Newborn; Magnesium Sulfate; Pregnancy; Premature Birth; Tocolytic Agents | 2009 |
[Magnesium sulphate: an improvement in the field of preterm infant neuroprotection].
Topics: Central Nervous System Diseases; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Premature Birth | 2010 |
Committee Opinion No. 455: Magnesium sulfate before anticipated preterm birth for neuroprotection.
Topics: Cerebral Palsy; Female; Humans; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Neuroprotective Agents; Obstetric Labor, Premature; Pregnancy; Premature Birth; Tocolytic Agents | 2010 |
Magnesium sulfate in women with threatened preterm birth.
Topics: Female; Humans; Magnesium Sulfate; Pregnancy; Premature Birth; Tocolytic Agents; Treatment Outcome | 2010 |
Magnesium for fetal neuroprotection.
Topics: Algorithms; Female; Fetal Diseases; Humans; Magnesium Sulfate; Nervous System Diseases; Neuroprotective Agents; Pregnancy; Premature Birth; Tocolysis; Tocolytic Agents | 2011 |
[Gynecology/Obstetrics. Magnesium sulfate for fetal neuroprotection in preterm delivery. Latest advances in contraception.].
Topics: Cerebral Palsy; Contraceptive Agents, Female; Female; Humans; Magnesium Sulfate; Pregnancy; Premature Birth; Tocolytic Agents | 2011 |
SOGC Clinical Practice Guideline. Magnesium sulphate for fetal neuroprotection.
Topics: Female; Humans; Infant, Newborn; Magnesium Sulfate; Neuroprotective Agents; Obstetric Labor, Premature; Pregnancy; Premature Birth; Tocolytic Agents | 2011 |
Magnesium sulfate for neuroprotection in patients at risk for early preterm delivery: not yet.
Topics: Cerebral Palsy; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Premature Birth; Risk Factors | 2011 |
Obstetric interventions beneficial to prematurely delivering newborn babies: antenatal corticostetroids, progesterone, magnesium sulfate.
Topics: Adrenal Cortex Hormones; Cerebral Palsy; Female; Fetal Death; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Premature Birth; Prenatal Care; Progesterone | 2012 |
Feasibility of implementing magnesium sulphate for neuroprotection in a tertiary obstetric unit.
Topics: Australia; Cerebral Palsy; Cohort Studies; Feasibility Studies; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Obstetric Labor, Premature; Pregnancy; Pregnancy Complications; Premature Birth; Retrospective Studies; Tertiary Care Centers; Translational Research, Biomedical | 2012 |
Patient safety checklist No. 7: magnesium sulfate before anticipated preterm birth for neuroprotection.
Topics: Checklist; Female; Humans; Infant, Premature, Diseases; Magnesium Sulfate; Nervous System Diseases; Patient Safety; Pregnancy; Premature Birth; Tocolytic Agents | 2012 |
Possible antenatal and perinatal related factors in development of cystic periventricular leukomalacia.
Topics: Apgar Score; Case-Control Studies; Causality; Cerebral Palsy; Chorioamnionitis; Comorbidity; Female; Gestational Age; Humans; Indomethacin; Infant, Newborn; Leukomalacia, Periventricular; Magnesium Sulfate; Multivariate Analysis; Pre-Eclampsia; Pregnancy; Premature Birth; Prenatal Exposure Delayed Effects; Retrospective Studies; Risk Assessment; Umbilical Cord | 2005 |
Can postgraduate courses in Maternal-Fetal Medicine change clinical attitude?
Topics: Anti-Inflammatory Agents; Attitude of Health Personnel; Cerclage, Cervical; Decision Making; Dexamethasone; Education, Continuing; Female; Fetal Membranes, Premature Rupture; Genetic Testing; Gynecology; HELLP Syndrome; Humans; Magnesium Sulfate; Midwifery; Obstetric Nursing; Obstetrics; Pregnancy; Premature Birth; Seizures; Surveys and Questionnaires; Thrombophilia; Tocolytic Agents; United States | 2005 |
Magnesium sulfate suppresses inflammatory responses by human umbilical vein endothelial cells (HuVECs) through the NFkappaB pathway.
Topics: Active Transport, Cell Nucleus; Cell Adhesion; Cell Nucleus; Cells, Cultured; Endothelial Cells; Female; Humans; I-kappa B Proteins; Inflammation; Inflammation Mediators; Intercellular Adhesion Molecule-1; Interleukin-8; Lipopolysaccharides; Magnesium Sulfate; NF-kappa B; NF-KappaB Inhibitor alpha; Pregnancy; Premature Birth; Tocolytic Agents; Umbilical Veins | 2007 |
A 24-year-old woman with abdominal pain.
Topics: Abdominal Pain; Adult; Anticonvulsants; Cesarean Section; Eclampsia; Emergency Service, Hospital; Epilepsy, Tonic-Clonic; Female; HELLP Syndrome; Humans; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Obesity, Morbid; Pregnancy; Pregnancy Tests; Premature Birth; Referral and Consultation; Ultrasonography, Prenatal | 2008 |